Identification of cis-regulatory mutations generating de novo edges in personalized cancer gene regulatory networks
Whole genome sequencing data on 10 human cancer cell lines
- 14 samples
- DAC: EGAC00001000782
- Technologies: Complete Genomics, Illumina Genome Analyzer IIx
Policy statement for the whole genome sequencing of 10 cancer cell lines study
This document refers to the data set, EGAS00001002571, which has been submitted to the European Genome Archive (EGA) for the restricted access by legitimate academic institutions that have agreed to comply with the terms of a Data Access Agreement drafted by DAC-CBD. There are a number of steps that a researcher must take to obtain access to this data and the process is overseen by our Data Access Committee, called DAC-CBD and can be contacted through Inge Laeremans (dac.cbd@kuleuven.vib.be). Please be advised that Zeynep Kalender Atak (zeynep.kalender@med.kuleuven.be) is authorized to upload data to the EGA for archiving and distribution as part of your submission process, which will enable approved researchers to have encrypted access to the data. We can confirm that this submission is consistent with the informed consent of the participants of the study or has been granted ethical approval and is in accordance with the applicable laws and regulations.
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
Study ID | Study Title | Study Type |
---|---|---|
EGAS00001002571 | Other |
This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.